CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DAO | D-amino-acid oxidase | Enzymes Predicted secreted proteins
| | | | | Group enriched |
DEPDC7 | DEP domain containing 7 | | | | | | Group enriched |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes
| | | | | Group enriched |
DIO1 | Deiodinase, iodothyronine, type I | Enzymes Predicted membrane proteins
| | | | | Group enriched |
DLGAP2 | Discs, large (Drosophila) homolog-associated protein 2 | Nuclear receptors
| | | | | Group enriched |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
DNMT3L | DNA (cytosine-5-)-methyltransferase 3-like | Transcription factors
| | | | | Group enriched |
DPYS | Dihydropyrimidinase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
DUSP15 | Dual specificity phosphatase 15 | Enzymes
| | | | | Group enriched |
DUSP9 | Dual specificity phosphatase 9 | Enzymes
| | | | | Group enriched |
EHHADH | Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins
| | | | | Group enriched |
ERBB4 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FAM151A | Family with sequence similarity 151, member A | | | | | | Group enriched |
FRMD7 | FERM domain containing 7 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
FTCD | Formimidoyltransferase cyclodeaminase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
GALNT9 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
GCGR | Glucagon receptor | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
GLTPD2 | Glycolipid transfer protein domain containing 2 | Predicted secreted proteins
| | | | | Group enriched |
GLYAT | Glycine-N-acyltransferase | Enzymes Mitochondrial proteins
| | | | | Group enriched |
GLYATL1 | Glycine-N-acyltransferase-like 1 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
HAO2 | Hydroxyacid oxidase 2 (long chain) | Enzymes
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
HPD | 4-hydroxyphenylpyruvate dioxygenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
HRSP12 | Heat-responsive protein 12 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | | | | | | Group enriched |
ILDR2 | Immunoglobulin-like domain containing receptor 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
KCNJ16 | Potassium inwardly-rectifying channel, subfamily J, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNJ3 | Potassium inwardly-rectifying channel, subfamily J, member 3 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
KLK6 | Kallikrein-related peptidase 6 | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KNG1 | Kininogen 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRTAP5-8 | Keratin associated protein 5-8 | | | | | | Group enriched |
LINC00955 | Long intergenic non-protein coding RNA 955 | Predicted membrane proteins
| | | | | Group enriched |
LYG1 | Lysozyme G-like 1 | Predicted secreted proteins
| | | | | Group enriched |
MGAM | Maltase-glucoamylase (alpha-glucosidase) | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MNS1 | Meiosis-specific nuclear structural 1 | | | | | | Group enriched |
MYLK4 | Myosin light chain kinase family, member 4 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
MYOM3 | Myomesin 3 | | | | | | Group enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
NXPH2 | Neurexophilin 2 | Predicted secreted proteins
| | | | | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PFN3 | Profilin 3 | Cytoskeleton related proteins
| | | | | Group enriched |
PIPOX | Pipecolic acid oxidase | Enzymes Plasma proteins
| | | | | Group enriched |
PKHD1 | Polycystic kidney and hepatic disease 1 (autosomal recessive) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |